ABSTRACT Objective: Although the genetic contribution to the development of anorexia nervosa (AN) has long been recognized, there has been little progress relative to other psychiatric disorders in identifying specific susceptibility genes. Here, we have carried out a genome-wide association study on an unselected community sample of female twins surveyed for eating disorders.
Introduction
Twin studies suggest that around 60% of the variance in risk for developing anorexia nervosa (AN) and disordered eating is due to genetic factors, [1] [2] [3] with more variable estimates attributed to bulimia nervosa (BN, ranging from 28 4 to 83% 5 ). Linkage studies identified regions on chromosomes 1, 2, 4, and 13 as suggestive of linkage for AN 6, 7 with follow-up significant association of the delta opioid receptor (OPRD1) and serotonin (5-HT) receptor 1D (HTR1D) genes, both on chromosome 1. 8 For BN, significant linkage was observed on chromosome 10 and another region on chromosome 14 was suggestive for genome-wide linkage. 9 Well over 200 candidate gene association studies of eating disorders have been conducted, focusing primarily, but not exclusively, on serotonergic, dopaminergic, and appetite regulatory genes; however, largely because of an overreliance on small samples, replication has not been universal and clear conclusions remain elusive (Trace et al., submitted).
The current preferred approach to rectifying the nebulous results emerging from a litany of underpowered studies is to boost power through metaanalyses of multiple genome-wide association studies (GWAS). In contrast to candidate gene association studies that focus on prespecified genes of interest, GWAS represent an unbiased scan of the entire genome for common genetic variation in cases versus healthy controls. To date, three GWAS investigations [10] [11] [12] have been published for eating disorders; none of which has yielded genome-wide significant single-nucleotide which examined six eating disorder-related symptoms, behaviors, and personality traits in 2,698 individuals, detected association of eight genetic variants with p \ 10 25 , and an associated metaanalysis showing five SNP markers (and associated genes) met genome-wide significance level: rs6894268 (RUFY1), rs7624327 (CCNL1), rs10519201 (SHC4), rs4853643 (SDPR), and rs218361 (TRPS1). A further GWAS of AN, conducted by the International Wellcome Trust Case Control Consortium (WTCCC3) on 2,907 patients with AN and 14,860 geographically matched controls, is in progress. 14 Eating disorders are associated with the highest mortality of any psychiatric disorder. [15] [16] [17] [18] Best evidence treatment approaches have been identified for bulimic disorders, 19 but the evidence base for how best to treat AN is weak. 20 There are no medications that are currently considered to be effective in the treatment of AN, and progress in this area has been hampered by a lack of knowledge about the underlying neurobiology of the condition. The clear-cut identification of genomic variation that predisposes to eating disorders can provide the basis for the next generation of research into etiology, treatment, and prevention.
In line with evidence that shows that large-scale collaborative GWAS studies and larger sample sizes can achieve the necessary power to identify specific loci in psychiatric disorders, 21, 22 the aim of this study is to contribute to the accumulation of a larger sample size related to disordered eating. This 
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International Journal of Eating Disorders 46:6 594-608 2013 study conducted a GWAS of four different phenotypes of disordered eating in an unselected sample of 2,564 female twins in order to further our knowledge of the genomic variation that predisposes to core features of eating disorders. This represents only the fourth published GWAS in eating disorders, and so a secondary aim was to see whether we could achieve any replication with the previously published studies.
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Method
Participants
Participants were from the volunteer adult Australian Twin Registry maintained by the National Health and Medical Research Council. These data are from two cohorts of women who completed a mailed questionnaire survey 1988-1992, as shown in Figure 1 . The first cohort, born before 1964, has been previously described, 3, 23, 24 and an examination of their sociodemographic features, including age, marital status, educational background, workforce participation, major lifetime occupation, and religious denomination, suggests that the sample is not notably different from the Australian female population (using data obtained from the Australian Bureau of Statistics between 1986 and 1992). The second cohort included women born between 1964 and 1971 and has also been previously described. 25, 26 Most of these twins had been recruited when at school some 10 years earlier. All applicable institutional regulations concerning the ethical use of human volunteers were followed during this research. The final combined sample where there were both phenotypic data for disordered eating and genotypes comprised 2,564 women.
Phenotypes
The 1988-1992 surveys mailed to female twins contained five questions assessing disordered eating and these are shown in Table 1 . These questions produced a total of 15 variables relating to disordered eating. A previous examination of these items along with two subsequent measures of eating disordered behavior indicated that 60% (95% CI: 50-68) of the variance could be attributed to additive genetic influences. 3 In the younger cohort, a follow-up telephone interview was conducted in 2001-2003 when they were aged 28-40 years (about 10 years after the self-report questionnaire) using the Eating Disorder Examination (EDE 27 ) with 1,083 women, indicating a moderate association (r 5 .31 and .38 for Twins 1 and 2, respectively) between the mean number of 16 possible problems endorsed in the self-report questionnaire and total number of six possible eating disorder behaviors endorsed at interview. 26 Moderate agreement is also obtained between two different interview schedules (including the EDE) assessing eating disorders 18-24 months apart, achieving a kappa value of \0.60.
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As shown in Figure 1 , four different phenotypes relating to disordered eating were examined. The first three phenotypes were derived from an exploratory factor analysis of the 15 variables for all available data, whether women had been genotyped or not. The resultant factors are shown in Table 1 , where items with factor loadings 0.2 are highlighted. Of interest to the current investigation were those factors that related to disordered eating, namely Factor 1 (AN spectrum), Factor 2 (BN spectrum), and Factor 3 (purging via substances).
For the fourth phenotype (disordered eating behaviors), the item relating to ''difficulty controlling weight'' was excluded as it was endorsed so widely that it was considered not to be indicative of disordered eating but rather of the normative struggle many women feel that they have with their weight. The remaining 14 items were reduced to a binary variable, where women who endorsed ''no'' for all items were grouped as ''controls,'' and women who endorsed three or more problems were grouped as ''cases.''
Genotyping
Genotypes were drawn from an existing QIMR Genetic Epidemiology Laboratory GWAS data for [19,000 individuals (comprised of twin pairs, nuclear families, or singletons), which integrates data from eight batches of genotyping obtained using standard Illumina chips. The subset used here includes individuals typed with the 610K-quad chip (1,138 individuals), 370K or 370K-duo chips (738 individuals), or the Illumina 317K chip (644 individuals); 316 individuals were genotyped on more than one chip either for deliberate QC reasons or to obtain higher coverage than an early-generation chip used previously. Individual genotypes were eliminated where they conflict between monozygotic twins or repeat genotypings, as well as (within each family) all genotypes for markers with Mendelian errors. All twin-family members were used in the genetic analysis, taking account of their relatedness (see below).
Within each batch, genotypes were called using the Genotyping Module in Beadstudio and then exported. Measured genotypes for the 281,000 SNPs passing QC in all genotyping batches were used to impute to 1000 Genomes SNPs (Release 20100804) via the recommended prephasing method in MACH and Minimac, 29 using the publicly available EUR-phased haplotypes as reference panel (from the formatted 1000 Genomes haplotype files supplied by the software authors' web site, for this purpose). In all, 7,262,007 SNPs were initially analyzed (this is after the R 2 quality control test but not the MAF test), and 6,150,213 SNPs remained after filtering out those with MAF \ 2%. As people genotyped already had their zygosity assessed previously in various ways, no twin pairs needed to be discarded due to discordance revealed by genotyping. The number of twins passing quality control varied by phenotype: 2,524 for the AN spectrum, 2,442 for the BN spectrum, 2,521 for purging via substances, 1,659 for the 14-item disordered eating score.
Statistical Analysis
Four case/control phenotypes were analyzed. To allow for both developmental and secular cohort effects on these phenotypes, we included age, age 2 , cohort, age 3 cohort, and age 2 3 cohort as covariates. Analyses were conducted using MERLIN-OFFLINE, which implements a total test of association using allele dosage scores while explicitly modeling the relationship structure within our MZ and DZ twin families. 30 Variants with poor imputation accuracy (R 2 \ 0.3) and rare variants (MAF \ 0.02)
were excluded from analyses.
Gene-based association tests were run on the association results for common variants using VEGAS 31 (v0.8.27). Note that VEGAS as currently configured identifies SNPs within genes based on the gene boundaries as defined by Build 36 (hg18) coordinates, and returns results in these coordinates. VEGAS results reported here have been converted to Build 37 (hg19) for consistency with other quoted positions. Because of software limitations, only SNPs found in HapMap II genotypes were analyzed, and results for the X chromosome are not available from VEGAS.
Results
Genome-Wide Association of SNP Data
The results of the GWAS analyses for each of our four binary eating disorder variables are summarized in the Manhattan plots presented in Figure 2 . LD pruned results for variants p \ 10 25 are provided in Table 2 . The top 100 gene-based results from VEGAS are listed in Table 3 .
Many of those with one (or few) associated SNPs per peak appear to represent false-positive signals, as either they are not in LD with adjoining SNPs or are in LD but adjoining SNPs are also not associated. Peaks shown with 2 SNPs in Table 2 were all manually inspected to ascertain if they contained a signal off the listed SNP(s). In the majority of instances, there is no association signal off the listed SNP(s) even without applying the ''MAF 2%'' filter to association results. In others there are other mildly associated SNPs with no signal in between. The most notable such exceptions have been footnoted in Table 2 .
The initial GWAS analyses yielded a number of suggestive association signals, although none ) which fail the p-value filter used here. reached genome-wide significance for common variants within 1 KGP imputed data of p \ 10 28 . Regional association plots for these suggestive signals are shown in Figure 3 . The power associated with our strongest SNPs (at p \ 10 25 ) was R 2 \ 0.5 for 9, R 2 \ 0.6 for 15, and R 2 \ 0.7 for 21, indicating that they were well imputed.
Attempted Replication of Results from the Previous GWAS Studies
We examined our results for the regions containing SNPs and CNV regions reported as associated with AN by Wang et al., 11 and the other previously reported associated SNPs reported earlier 12, 32 and in a Japanese population, 10 replication of which was tested in Wang et al. The p-values for the relevant SNPs in our data are reported in Table 4 , along with MAF from our imputed data and the referenced papers (all for Europeans by Wang et al. 11 and for Japanese by Nakabayashi et al. 10 ) for rs2048332. Our frequencies are consistent with the range between case and control frequencies for Wang et al. 11 (suggesting good imputation) but we fail to replicate (in any of our phenotypes) their associated SNPs for AN or those reported earlier. 10, 12, 32 We do find a nominally significant association (p .01) in both the BN spectrum and 14-item disordered eating behavior variable for rs906281, which Wang et al. 11 investigated as a proxy for rs2048332 which was itself reported by Nakabayashi et al. 10 However, this is significant only in terms of the limited number of tests shown in Table 4 , and is for a different population.
Discussion
This study represents only the fourth published GWAS for eating disorders-related phenotypes and extends the literature by examining four broad eating disorder phenotypes assessed by self-report-AN spectrum, BN spectrum, purging via substances, and disordered eating behaviors. A number of suggestive signals were identified, although none reached genome-wide significance at the level of p \ 10
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. The strongest evidence of association was observed at rs145241704, rs62090893, and rs561 56506 for the AN spectrum phenotype, rs1445130 for the BN spectrum phenotype, rs138206701 for the purging phenotype, and rs7322916 for the disordered eating behaviors phenotype.
The strongest signal for our AN spectrum variable is located in a gene-rich region on chromosome 7 (141.5Mb). Within this region are a number of promising positional candidates. The peak variant in this region, rs145241704, is located within the mRNA DQ571874, which has previously been identified as a Piwi-interacting RNA playing a role in gamete development. However, the LD block within this region includes a number of taste receptor genes including TAS2R3, TAS2R4, and TAS2R5, which encode bitter taste receptors. Such receptors have previously been shown to influence perception and eating behaviors with respect to certain foods. Also within this region is CLEC5A, which is a carbohydrate-binding protein domain that has a diverse range of functions including cell-cell adhesion, immune response to pathogens, and apoptosis. The next strongest signal, which peaked at rs62090893, encompasses the TSHZ1 gene. Notably, in a recent study examining changes in gene expression in response to bariatric surgery in a sample of patients with Type 2 diabetes, 33 changes in expression of TSHZ1 were correlated with changes in weight, fasting plasma glucose, and glycosylated hemoglobin.
The strongest result for the BN spectrum phenotype was located in an intergenic region centered around rs1445130 on chromosome 2. Recent results from the ENCODE consortium have shown enrichment of the H3K27Ac histone marks within this region, suggesting that there may be an active regulatory region nearby. The closest gene, NT5C1B, plays a role in the production of adenosine, which plays an important role in biochemical processes, such as energy transfer.
Consistent with research in other areas of psychiatric genetics prior to accumulation of large sample sizes, there was no meaningful replication between previous genome-wide studies of AN and our current results. If eating disorders follow the same scientific trajectory of other medical and psychiatric disorders, which is increased replication and clarity with increasingly large sample sizes 34 -and there are not theoretical reasons why they should notthen we would expect more concrete results as we combine samples into meta-analyses.
This study has a number of limitations; first, we used self-report data that are not directly reflective of the diagnostic criteria for eating disorders. Although our data cluster in recognizable eating disorder syndromes, 24 the phenotypes represent rather a blunt instrument for identifying specific eating disorders. Second, as with other studies of psychiatric illness that have used population-based samples, the analyses are underpowered. Third, there are only 45 persons who would qualify for a diagnosis of BN or AN in our genotyped sample, 35 so our ability to contribute cases to larger casecontrol samples is limited. However, GWAS now exist that are not focused on diagnosis but on eating disorder-related symptoms and behaviors. 12 As GWAS meta-analysis by definition requires the availability of a number of samples, and a review of the genetic architecture of psychiatric disorders shows that sample size is of greater importance FIGURE 3. Association peak regional plots of per-SNP association p-values for (1) the most highly associated but plausible association peaks for each phenotype (i.e., containing a group of adjoining associated SNPs in high LD); (2) additional associated genes (highlighted in bold in Tables 2 and 3 than heritability with respect to the identification of specific loci, 21 our analyses should make a useful contribution toward improving the power to identify genetic variants influencing symptoms and behaviors related to eating disorders through the conduct of meta-and mega-analyses with other such GWAS.
